These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25097214)

  • 21. Statin prescribing fell after drug became available over the counter.
    Dobson R
    BMJ; 2006 Sep; 333(7568):569. PubMed ID: 16974003
    [No Abstract]   [Full Text] [Related]  

  • 22. Improving long-term adherence to statin therapy: a qualitative study of GPs' experiences in primary care.
    Krüger K; Leppkes N; Gehrke-Beck S; Herrmann W; Algharably EA; Kreutz R; Heintze C; Filler I
    Br J Gen Pract; 2018 Jun; 68(671):e401-e407. PubMed ID: 29686133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mass treatment with statins.
    Goldacre B; Smeeth L
    BMJ; 2014 Jul; 349():g4745. PubMed ID: 25056140
    [No Abstract]   [Full Text] [Related]  

  • 24. Statin Prescription Rates in Children With Severe Dyslipidemia in the United States.
    Umapathi KK; Thavamani A
    Am J Cardiol; 2020 Sep; 131():139-140. PubMed ID: 32718557
    [No Abstract]   [Full Text] [Related]  

  • 25. [Transferring to the practice the results of the clinical trials with statins: from the relative risk to the absolute risk].
    Martín-Luján F; Baldrich-Justel M; Bejarano-Romero F
    Med Clin (Barc); 2005 Dec; 125(20):799. PubMed ID: 16373038
    [No Abstract]   [Full Text] [Related]  

  • 26. Optimal Prescribing of Statins to Reduce Cardiovascular Disease.
    Schade DS; Duro T; Eaton RP
    Am J Med; 2023 Dec; 136(12):1133-1135. PubMed ID: 37572739
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice.
    Chatelin J; Stathopoulou MG; Arguinano AA; Xie T; Visvikis-Siest S
    Curr Pharm Biotechnol; 2017; 18(3):231-241. PubMed ID: 28117005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Audit-based education to reduce suboptimal management of cholesterol in primary care: a before and after study.
    de Lusignan S; Belsey J; Hague N; Dhoul N; van Vlymen J
    J Public Health (Oxf); 2006 Dec; 28(4):361-9. PubMed ID: 17038329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PCSK9 inhibitors and diabetes: Translational biology to clinical practice.
    Chilton RJ; Oliveros R; Gallegos KM; Pham S
    Diabetes Obes Metab; 2019 Mar; 21(3):451-453. PubMed ID: 30520245
    [No Abstract]   [Full Text] [Related]  

  • 30. Statin use among older Finns stratified according to cardiovascular risk.
    Upmeier E; Korhonen MJ; Helin-Salmivaara A; Huupponen R
    Eur J Clin Pharmacol; 2013 Feb; 69(2):261-7. PubMed ID: 22706622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Starting statins for primary prevention of cardiovascular disease.
    Tunstall-Pedoe H
    Heart; 2013 Nov; 99(21):1547-8. PubMed ID: 23878178
    [No Abstract]   [Full Text] [Related]  

  • 32. Statins evidence: when answers also raise questions.
    Krumholz HM
    BMJ; 2016 Sep; 354():i4963. PubMed ID: 27628589
    [No Abstract]   [Full Text] [Related]  

  • 33. Middle-aged man who could not afford an angioplasty.
    Podder V; Price A; Sivapuram MS; Biswas R
    BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30936331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decisions on statin therapy by patients' opinions about survival gains: cross sectional survey of general practitioners.
    Halvorsen PA; Aasland OG; Kristiansen IS
    BMC Fam Pract; 2015 Jul; 16():79. PubMed ID: 26139240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variations in lipid screening frequency in family medicine patients with cardiovascular risk factors.
    Doganer YC; Rohrer JE; Angstman KB; Merry SP; Erickson JL
    J Eval Clin Pract; 2015 Apr; 21(2):215-20. PubMed ID: 25394299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. All people over 75 years with a five-year CVD risk of ≥15% should be treated with statins unless specifically contraindicated: no.
    Mangin D
    J Prim Health Care; 2010 Dec; 2(4):333-5. PubMed ID: 21125076
    [No Abstract]   [Full Text] [Related]  

  • 37. How surgeons make decisions: authority and evidence.
    Obertop H
    Ann Surg; 2005 Dec; 242(6):753-6. PubMed ID: 16327484
    [No Abstract]   [Full Text] [Related]  

  • 38. Provider adherence to clinical guidelines related to lipid-lowering medications.
    Cohen SM; Kataoka-Yahiro M
    Mil Med; 2010 Feb; 175(2):122-6. PubMed ID: 20180482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of electronic prescription on attainment of cholesterol goals.
    Michelis KC; Hassouna B; Owlia M; Kelahan L; Young HA; Choi BG
    Clin Cardiol; 2011 Apr; 34(4):254-60. PubMed ID: 21462218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statins and safety: applying the results of randomized trials to clinical practice.
    Waters D
    Am J Cardiol; 2003 Sep; 92(6):692-5. PubMed ID: 12972108
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.